GlassScriptPhysician profile
Michael J Lloyd
NPI 1124239009
$871.14
in general payments reported to CMS, 2019-2025
12 companies · $76.04 in 2025
The $76.04 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $195 · 2021: $80.71 · 2022: $120 · 2023: $147 · 2024: $81.55 · 2025: $76.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $240.20 | 2019-2021 | |
| Alcon Vision LLC | $233.26 | 2019-2025 | Hydrus Microstent, Rocklatan, Clareon |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.05 | 2019 | |
| Abbvie INC. | $78.63 | 2022-2024 | |
| Rxsight INC | $64.99 | 2022-2024 | Rxsight Contact Lens, Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Sight Sciences, INC. | $37.77 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Tarsus Pharmaceuticals, INC. | $26.97 | 2025 | Xdemvy |
| Glaukos Corporation | $26.94 | 2019 | |
| Thea Pharma INC. | $19.47 | 2025 | Iyuzeh |
| Shire North American Group INC | $16.52 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $15.53 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lloyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.